focus -WSS

focus

author：comprehensive 2025-10-02 15:44:20 - browse：5627

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Why are Kaiser Permanente staff considering a strike?

hotspot

knowledge

WSS

Why are Kaiser Permanente staff considering a strike?

UnitedHealth’s board chair also owns a personal investment firm

Ukraine and a new approach to mental health in war

How climate

Pharmacists can make shortage drugs, but at what cost?

Studies point to risks of excluding people with obesity from drug trials

leisure time

focus

focus

Anesthesiologist group: stop taking Ozempic before surgery

First Opinion Podcast: Long Covid needs a new approach

Activists slam private health insurers over coverage restrictions

What Congress can do to address the rural doctor shortage

Walensky prepares to leave CDC — and Congress — behind

2023 STAT Wunderkinds: get to know the winners

BioMarin wins approval for gene therapy to treat hemophilia A

Biotech lab space demand falls sharply

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Senators: Long

explore

HHS leader on health, climate change and biopharma emissions

Emergency workers more likely to restrain Black patients: study

STAT Virtual Event: Putting AI to the Test

STAT Summit: Biotech founders on deal

First Opinion Podcast: Long Covid needs a new approach

Senators: Long

hotspot

knowledge

focus

focus